Great West Life Assurance Co. Can decreased its holdings in shares of PetMed Express, Inc. (NASDAQ:PETS) by 11.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 22,758 shares of the company’s stock after selling 3,026 shares during the quarter. Great West Life Assurance Co. Can owned about 0.11% of PetMed Express worth $721,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds have also modified their holdings of PETS. FMR LLC raised its holdings in PetMed Express by 9,448.1% during the 1st quarter. FMR LLC now owns 5,156 shares of the company’s stock valued at $118,000 after acquiring an additional 5,102 shares during the period. Amundi Pioneer Asset Management Inc. bought a new position in shares of PetMed Express in the first quarter worth $2,475,000. California Public Employees Retirement System increased its holdings in shares of PetMed Express by 0.9% in the second quarter. California Public Employees Retirement System now owns 44,026 shares of the company’s stock worth $1,569,000 after purchasing an additional 414 shares during the period. Commonwealth Equity Services LLC increased its holdings in shares of PetMed Express by 27.3% in the second quarter. Commonwealth Equity Services LLC now owns 10,963 shares of the company’s stock worth $390,000 after purchasing an additional 2,350 shares during the period. Finally, American International Group Inc. increased its holdings in shares of PetMed Express by 2.6% in the second quarter. American International Group Inc. now owns 13,886 shares of the company’s stock worth $495,000 after purchasing an additional 351 shares during the period. 92.75% of the stock is currently owned by institutional investors and hedge funds.
Several research firms have recently weighed in on PETS. ValuEngine cut shares of PetMed Express from a “hold” rating to a “sell” rating in a report on Tuesday, November 3rd. BidaskClub raised shares of PetMed Express from a “sell” rating to a “hold” rating in a report on Thursday, December 17th.
PetMed Express (NASDAQ:PETS) last released its earnings results on Saturday, October 31st. The company reported $0.42 EPS for the quarter, beating the Zacks’ consensus estimate of $0.40 by $0.02. The business had revenue of $75.40 million for the quarter, compared to analysts’ expectations of $77.05 million. PetMed Express had a return on equity of 21.91% and a net margin of 9.41%. The firm’s revenue was up 7.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.33 earnings per share.
In related news, Director Ronald J. Korn sold 2,000 shares of the stock in a transaction on Thursday, December 24th. The stock was sold at an average price of $34.00, for a total value of $68,000.00. Following the transaction, the director now owns 85,333 shares of the company’s stock, valued at $2,901,322. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In the last three months, insiders sold 6,000 shares of company stock worth $198,000. 3.60% of the stock is owned by insiders.
PetMed Express Profile
PetMed Express, Inc, together with its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, and other health products for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventative, flea and tick preventative, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.
See Also: What is a support level?
Receive News & Ratings for PetMed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express and related companies with MarketBeat.com's FREE daily email newsletter.